Evolent Health (NYSE: EVH) revenue
Evolent Health reported revenue of $1,876m for fiscal 2025, 26.6% less than in fiscal 2024 ($2,555m). Since fiscal 2016 its revenue has grown by 638.1%, an average growth of 24.9% a year.
Evolent Health's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −26.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,876m | −26.6% | −$410.1m | −21.9% |
| 2024 | $2,555m | +30.1% | −$40.5m | −1.6% |
| 2023 | $1,964m | +45.3% | −$71.2m | −3.6% |
| 2022 | $1,352m | +48.9% | $3.6m | 0.3% |
| 2021 | $908.0m | −1.8% | −$42.4m | −4.7% |
| 2020 | $924.6m | +34.6% | −$262.8m | −28.4% |
| 2019 | $687.1m | +9.6% | −$308.9m | −45.0% |
| 2018 | $627.1m | +44.2% | −$47.5m | −7.6% |
| 2017 | $435.0m | +71.1% | −$72.8m | −16.7% |
| 2016 | $254.2m | — | −$237.4m | −93.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Evolent Health revenue compared with its sector
By revenue for its latest fiscal year, Evolent Health ranks 118th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Evolent Health, −26.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 116th | Clover Health Investments | $1,924m | 40.3% |
| 117th | Pediatrix Medical Group | $1,914m | −4.9% |
| 118th | Evolent Health | $1,876m | −26.6% |
| 119th | Integer | $1,854m | 8.0% |
| 120th | Healthcare Services Group | $1,837m | 7.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Evolent Health
- How much revenue did Evolent Health make in fiscal 2025?
- Evolent Health reported revenue of $1,876m for fiscal 2025, compared with $2,555m in fiscal 2024.
- How much has the revenue of Evolent Health grown?
- Between fiscal 2016 and fiscal 2025 it went from $254.2m to $1,876m: 638.1% more, an average growth of 24.9% a year.
- What was the best year for revenue at Evolent Health?
- Of its last 10 fiscal years, fiscal 2024, with $2,555m.
- Where does Evolent Health rank in its sector by revenue?
- It ranks 118th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Evolent Health come from?
- From the annual report (Form 10-K) that Evolent Health files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Evolent Health files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Evolent Health: the Evolent Health page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.